Bankda family succession: senior directors exit, next-gen takes MD and CFO roles
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.6 pts more than Nifty Microcap 250 and 9.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syncom Formulations announced a top-level succession on Aug 11. Whole-time Director Kedarmal Bankda resigned citing health, and Managing Director Vijay Bankda stepped down citing leadership transition. CFO Rahul Bankda also resigned. From Aug 12, Rahul Bankda (son of past MD, promoter group) becomes new Managing Director, Ankur Bankda (also promoter group) becomes CFO, and Rinki Bankda joins as Whole-time Director. Ruchi Jindal is reappointed as Woman Independent Director.
Continuity assured as Bankda promoter family hands leadership to next generation; likely seen as stable succession by shareholders.